MOLN Projected Dividend Yield
ADR/Molecular Partners AG ( NASDAQ : MOLN )Molecular Partners AG is a clinical stage biopharmaceutical company. Co. is developing a new class of therapies known as DARPin® therapies. Co. is applying its pioneering DARPin® product engine to treat serious diseases, with an initial focus on oncology, immuno-oncology and ophthalmology. 20 YEAR PERFORMANCE RESULTS |
MOLN Dividend History Detail MOLN Dividend News MOLN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |